2023-08-11 11:59:24 ET
- BioXcel Therapeutics ( NASDAQ: BTAI ) is scheduled to announce Q2 earnings results on Monday, August 14th, before market open.
- The consensus EPS Estimate is -$1.73 and the consensus Revenue Estimate is $0.47M.
- Over the last 1 year, BTAI has beaten EPS estimates 25% of the time and has beaten revenue estimates 0% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 5 downward. Revenue estimates have seen 0 upward revisions and 6 downward.
For further details see:
BioXcel Therapeutics Q2 2023 Earnings Preview